000			02096 a2200565 4500
005			20250517143143.0
264		0	_c20170613
008			201706s 0 0 eng d
022			_a1432-0843
024	7		_a10.1007/s00280-017-3268-y _2doi
040			_aNLM _beng _cNLM
100	1		_aTandia, Mahamadou
245	0	0	_aCorrelation between clinical response to sorafenib in hepatocellular carcinoma treatment and polymorphisms of P-glycoprotein (ABCB1) and of breast cancer resistance protein (ABCG2): monocentric study. _h[electronic resource]
260			_bCancer chemotherapy and pharmacology _c04 2017
300			_a759-766 p. _bdigital
500			_aPublication Type: Journal Article
650	0	4	_aATP Binding Cassette Transporter, Subfamily B _xgenetics
650	0	4	_aATP Binding Cassette Transporter, Subfamily G, Member 2 _xgenetics
650	0	4	_aAdult
650	0	4	_aAged
650	0	4	_aAged, 80 and over
650	0	4	_aAntineoplastic Agents _xpharmacokinetics
650	0	4	_aBreast Neoplasms _xdrug therapy
650	0	4	_aCarcinoma, Hepatocellular _xdrug therapy
650	0	4	_aDNA _xgenetics
650	0	4	_aDrug Monitoring
650	0	4	_aFemale
650	0	4	_aGenotype
650	0	4	_aHumans
650	0	4	_aLiver Neoplasms _xdrug therapy
650	0	4	_aMale
650	0	4	_aMiddle Aged
650	0	4	_aNeoplasm Proteins _xgenetics
650	0	4	_aNiacinamide _xanalogs & derivatives
650	0	4	_aPhenylurea Compounds _xpharmacokinetics
650	0	4	_aPolymorphism, Genetic _xgenetics
650	0	4	_aPolymorphism, Single Nucleotide _xgenetics
650	0	4	_aProtein Kinase Inhibitors _xpharmacokinetics
650	0	4	_aSorafenib
650	0	4	_aTreatment Outcome
700	1		_aMhiri, Asma
700	1		_aPaule, Bernard
700	1		_aSaffroy, Raphaël
700	1		_aCailliez, Valérie
700	1		_aNoé, Gaëlle
700	1		_aFarinotti, Robert
700	1		_aBonhomme-Faivre, Laurence
773	0		_tCancer chemotherapy and pharmacology _gvol. 79 _gno. 4 _gp. 759-766
856	4	0	_uhttps://doi.org/10.1007/s00280-017-3268-y _zAvailable from publisher's website
999			_c26964862 _d26964862